The 36-month beta value for VERU is at -0.78. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for VERU is 119.15M, and currently, shorts hold a 12.14% of that float. The average trading volume for VERU on June 10, 2025 was 2.21M shares.
VERU) stock’s latest price update
Veru Inc (NASDAQ: VERU) has seen a rise in its stock price by 1.74 in relation to its previous close of 0.64. However, the company has experienced a 6.46% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-28 that –Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone– –Based on Phase 2b QUALITY trial efficacy and safety data, enobosarm 3mg will advance as the proposed oral dose for the Phase 3 clinical program– — Enobosarm 3mg + semaglutide combination had the added benefit of fewer gastrointestinal side effects (Diarrhea, Nausea, and GERD) compared to semaglutide alone–
VERU’s Market Performance
Veru Inc (VERU) has experienced a 6.46% rise in stock performance for the past week, with a 30.34% rise in the past month, and a 32.90% rise in the past quarter. The volatility ratio for the week is 6.22%, and the volatility levels for the past 30 days are at 4.45% for VERU. The simple moving average for the past 20 days is 19.49% for VERU’s stock, with a -1.74% simple moving average for the past 200 days.
Analysts’ Opinion of VERU
Many brokerage firms have already submitted their reports for VERU stocks, with B. Riley Securities repeating the rating for VERU by listing it as a “Buy.” The predicted price for VERU in the upcoming period, according to B. Riley Securities is $5 based on the research report published on May 14, 2024 of the previous year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see VERU reach a price target of $3. The rating they have provided for VERU stocks is “Outperform” according to the report published on March 28th, 2024.
Jefferies gave a rating of “Hold” to VERU, setting the target price at $1 in the report published on June 07th of the previous year.
VERU Trading at 20.93% from the 50-Day Moving Average
After a stumble in the market that brought VERU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.79% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at VERU starting from Rankowitz Michael L, who purchase 95,279 shares at the price of $0.55 back on Feb 18 ’25. After this action, Rankowitz Michael L now owns 195,279 shares of Veru Inc, valued at $52,432 using the latest closing price.
Rankowitz Michael L, the Director of Veru Inc, purchase 54,721 shares at $0.58 during a trade that took place back on Feb 19 ’25, which means that Rankowitz Michael L is holding 250,000 shares at $31,919 based on the most recent closing price.
Stock Fundamentals for VERU
Current profitability levels for the company are sitting at:
- -3.54 for the present operating margin
- 0.38 for the gross margin
The net margin for Veru Inc stands at -3.43. The total capital return value is set at -1.39. Equity return is now at value -88.03, with -55.83 for asset returns.
Based on Veru Inc (VERU), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at -8.58. The debt to equity ratio resting at 0.16. The interest coverage ratio of the stock is -126.23.
Currently, EBITDA for the company is -36.2 million with net debt to EBITDA at 0.45. When we switch over and look at the enterprise to sales, we see a ratio of 7.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.80.
Conclusion
In conclusion, Veru Inc (VERU) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
